Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment

by Locker Gottfried J, Altorjai Gabriela, Sevelda Ursula, Hussian Dagmar, Pluschnig Ursula, Wenzel Catharina, Bartsch Rupert, Mader Robert, Zielinski Christoph C, Steger Guenther G
Published 2006-03-01

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study

by Locker Gottfried J, Altorjai Gabriela, Koestler Wolfgang, Sevelda Ursula, Pluschnig Ursula, Hussian Dagmar, Wenzel Catharina, Bartsch Rupert, Mader Robert, Zielinski Christoph C, Steger Guenther G
Published 2006-03-01

Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma

by Vogl Ursula M, Bojic Marija, Lamm Wolfgang, Frischer Josa M, Pichelmayer Oskar, Kramer Gero, Haitel Andrea, Kitz Klaus, Harmankaya Kaan, Zielinski Christoph C, Schmidinger Manuela
Published 2010-09-01

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

by Rottenfusser Andrea, Mader Robert M, Rudas Margaretha, Gampenrieder Simon P, Bago-Horvath Zsuzsanna, Dubsky Peter, Pluschnig Ursula, De Vries Catharina, Bartsch Rupert, Wiltschke Christoph, Gnant Michael, Zielinski Christoph C, Steger Guenther G
Published 2009-10-01